var eventsData = [{"Ticker":"NOV","EffectiveDate":"2017-02-08","Type":"RatingUpgrade","Title":"Credit Suisse upgrades NOV to Neutral from Underperform.","DailyReturn":"-0.2%","FiveDayReturnAfter":null,"FiveDayReturnBefore":"3.83%"},{"Ticker":"NOV","EffectiveDate":"2017-02-07","Type":"RatingNeutral","Title":"Loop Capital initiates coverage on NOV to Hold.","DailyReturn":"4.88%","FiveDayReturnAfter":null,"FiveDayReturnBefore":"-0.24%"},{"Ticker":"NOV","EffectiveDate":"2017-02-07","Type":"EarningsRevenueBeat","Title":"Before market open, NOV reports 2016 Q4's earning $-0.15 per share and revenue $1692MM. This beats analyst's estimated EPS $-0.28, beats estimated revenue $1620MM.","DailyReturn":"4.88%","FiveDayReturnAfter":null,"FiveDayReturnBefore":"-0.24%"},{"Ticker":"NOV","EffectiveDate":"2017-01-19","Type":"RatingUpgrade","Title":"Societe Generale upgrades NOV to Buy from Hold.","DailyReturn":"1.28%","FiveDayReturnAfter":"5.96%","FiveDayReturnBefore":"-0.9%"},{"Ticker":"NOV","EffectiveDate":"2016-12-09","Type":"RatingNeutral","Title":"Johnson Rice downgrades NOV to Hold from Accumulate.","DailyReturn":"-0.25%","FiveDayReturnAfter":"-0.45%","FiveDayReturnBefore":"5.91%"},{"Ticker":"NOV","EffectiveDate":"2016-12-01","Type":"RatingNeutral","Title":"Seaport Global downgrades NOV to Sell from Accumulate.","DailyReturn":"0.61%","FiveDayReturnAfter":"5.26%","FiveDayReturnBefore":"2.88%"},{"Ticker":"NOV","EffectiveDate":"2016-11-30","Type":"Dividend","Title":"The Firm pays dividend $0.05","DailyReturn":"8.13%","FiveDayReturnAfter":"13.05%","FiveDayReturnBefore":"-5.18%"},{"Ticker":"NOV","EffectiveDate":"2016-11-09","Type":"Item_8.01","Title":"Other 8-K Events\r\n","DailyReturn":"3.25%","FiveDayReturnAfter":"12.17%","FiveDayReturnBefore":"-0.06%"},{"Ticker":"NOV","EffectiveDate":"2016-11-07","Type":"RatingUpgrade","Title":"Citigroup upgrades NOV to Neutral from Sell.","DailyReturn":"1.12%","FiveDayReturnAfter":"4.47%","FiveDayReturnBefore":"-3.24%"},{"Ticker":"NOV","EffectiveDate":"2016-11-07","Type":"RatingUpgrade","Title":"Citigroup upgrades NOV to Neutral from Sell.","DailyReturn":"1.12%","FiveDayReturnAfter":"4.47%","FiveDayReturnBefore":"-3.24%"},{"Ticker":"NOV","EffectiveDate":"2016-10-26","Type":"Item_2.02","Title":"Release results of operational and financial condition\r\n","DailyReturn":"1.1%","FiveDayReturnAfter":"-12.44%","FiveDayReturnBefore":"-1.37%"},{"Ticker":"NOV","EffectiveDate":"2016-10-26","Type":"EarningsRevenueMiss","Title":"After market close, NOV reports 2016 Q3's earning $-0.34 per share and revenue $1646MM. This misses analyst's estimated EPS $-0.28, misses estimated revenue $1680MM.","DailyReturn":"1.1%","FiveDayReturnAfter":"-12.44%","FiveDayReturnBefore":"-1.37%"},{"Ticker":"NOV","EffectiveDate":"2016-10-26","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":"1.1%","FiveDayReturnAfter":"-12.44%","FiveDayReturnBefore":"-1.37%"},{"Ticker":"NOV","EffectiveDate":"2016-10-03","Type":"RatingNeutral","Title":"Citigroup downgrades NOV to Sell from Neutral. Target Price is $30; previously $37.","DailyReturn":"-1.57%","FiveDayReturnAfter":"0.27%","FiveDayReturnBefore":"8.07%"},{"Ticker":"NOV","EffectiveDate":"2016-09-30","Type":"RatingNeutral","Title":"Loop Capital initiates coverage on NOV to Hold. Target Price is $37.","DailyReturn":"-0.32%","FiveDayReturnAfter":"0.4%","FiveDayReturnBefore":"6.96%"},{"Ticker":"NOV","EffectiveDate":"2016-09-14","Type":"Dividend","Title":"The Firm pays dividend $0.05","DailyReturn":"-2.2%","FiveDayReturnAfter":"-3.47%","FiveDayReturnBefore":"-3.53%"},{"Ticker":"NOV","EffectiveDate":"2016-09-12","Type":"RatingNeutral","Title":"Citigroup maintains NOV to Neutral. Target Price is $37; previously $36.","DailyReturn":"2.77%","FiveDayReturnAfter":"-0.72%","FiveDayReturnBefore":"0.33%"},{"Ticker":"NOV","EffectiveDate":"2016-07-29","Type":"RatingUpgrade","Title":"Johnson Rice upgrades NOV to Accumulate from Hold.","DailyReturn":"0.96%","FiveDayReturnAfter":"1.6%","FiveDayReturnBefore":"-2.52%"},{"Ticker":"NOV","EffectiveDate":"2016-07-28","Type":"EarningsBeatRevenueMiss","Title":"Before market open, NOV reports 2016 Q2's earning $-0.3 per share and revenue $1724MM. This beats analyst's estimated EPS $-0.32, misses estimated revenue $1790MM.","DailyReturn":"2.46%","FiveDayReturnAfter":"4.34%","FiveDayReturnBefore":"-5.23%"},{"Ticker":"NOV","EffectiveDate":"2016-07-28","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":"2.46%","FiveDayReturnAfter":"4.34%","FiveDayReturnBefore":"-5.23%"},{"Ticker":"NOV","EffectiveDate":"2016-07-28","Type":"Item_2.02","Title":"Release results of operational and financial condition\r\n","DailyReturn":"2.46%","FiveDayReturnAfter":"4.34%","FiveDayReturnBefore":"-5.23%"},{"Ticker":"NOV","EffectiveDate":"2016-07-11","Type":"RatingNeutral","Title":"Jefferies maintains NOV to Hold. Target Price is $33; previously $30.","DailyReturn":"-1.22%","FiveDayReturnAfter":"3.46%","FiveDayReturnBefore":"-3.2%"},{"Ticker":"NOV","EffectiveDate":"2016-06-13","Type":"RatingNeutral","Title":"Bank of America assumes NOV to Underperform.","DailyReturn":"-1.25%","FiveDayReturnAfter":"0.42%","FiveDayReturnBefore":"8.9%"},{"Ticker":"NOV","EffectiveDate":"2016-06-08","Type":"Dividend","Title":"The Firm pays dividend $0.05","DailyReturn":"2.15%","FiveDayReturnAfter":"-5.85%","FiveDayReturnBefore":"9.54%"},{"Ticker":"NOV","EffectiveDate":"2016-05-18","Type":"Item_5.07","Title":"Submission of Matters to a Vote of Security Holders\r\n","DailyReturn":"-4.17%","FiveDayReturnAfter":"-4.13%","FiveDayReturnBefore":"3.28%"},{"Ticker":"NOV","EffectiveDate":"2016-05-04","Type":"RatingNeutral","Title":"Societe Generale downgrades NOV to Sell from Hold.","DailyReturn":"-3.87%","FiveDayReturnAfter":"-9.19%","FiveDayReturnBefore":"17.02%"},{"Ticker":"NOV","EffectiveDate":"2016-04-28","Type":"EarningsBeatRevenueMiss","Title":"Before market open, NOV reports 2016 Q1's earning $-0.06 per share and revenue $2189MM. This beats analyst's estimated EPS $-0.07, misses estimated revenue $2260MM.","DailyReturn":"4.41%","FiveDayReturnAfter":"5.43%","FiveDayReturnBefore":"9.94%"},{"Ticker":"NOV","EffectiveDate":"2016-04-28","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":"4.41%","FiveDayReturnAfter":"5.43%","FiveDayReturnBefore":"9.94%"},{"Ticker":"NOV","EffectiveDate":"2016-04-28","Type":"Item_2.02","Title":"Release results of operational and financial condition\r\n","DailyReturn":"4.41%","FiveDayReturnAfter":"5.43%","FiveDayReturnBefore":"9.94%"},{"Ticker":"NOV","EffectiveDate":"2016-04-27","Type":"RatingUpgrade","Title":"Morgan Stanley upgrades NOV to Overweight from Underweight. Target Price is $45; previously $39.","DailyReturn":"7.93%","FiveDayReturnAfter":"17.02%","FiveDayReturnBefore":"0.51%"},{"Ticker":"NOV","EffectiveDate":"2016-04-20","Type":"RatingNeutral","Title":"Barclays downgrades NOV to Equal-weight from Overweight. Target Price is $33.","DailyReturn":"-1.77%","FiveDayReturnAfter":"0.51%","FiveDayReturnBefore":"4.87%"},{"Ticker":"NOV","EffectiveDate":"2016-04-19","Type":"RatingNeutral","Title":"Morgan Stanley maintains NOV to Underweight. Target Price is $39; previously $35.","DailyReturn":"3.39%","FiveDayReturnAfter":"3.68%","FiveDayReturnBefore":"3.38%"},{"Ticker":"NOV","EffectiveDate":"2016-04-07","Type":"RatingNeutral","Title":"Nomura initiates coverage on NOV to Neutral. Target Price is $29.","DailyReturn":"-2.22%","FiveDayReturnAfter":"-0.03%","FiveDayReturnBefore":"-6.23%"},{"Ticker":"NOV","EffectiveDate":"2016-04-05","Type":"Item_5.02","Title":"Change of exectives and board members.\r\n","DailyReturn":"-1.89%","FiveDayReturnAfter":"-7.98%","FiveDayReturnBefore":"-6.22%"},{"Ticker":"NOV","EffectiveDate":"2016-04-05","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":"-1.89%","FiveDayReturnAfter":"-7.98%","FiveDayReturnBefore":"-6.22%"},{"Ticker":"NOV","EffectiveDate":"2016-03-09","Type":"RatingNeutral","Title":"Susquehanna maintains NOV to Neutral. Target Price is $30; previously $27.","DailyReturn":"1.09%","FiveDayReturnAfter":"6.45%","FiveDayReturnBefore":"6.52%"},{"Ticker":"NOV","EffectiveDate":"2016-03-09","Type":"Dividend","Title":"The Firm pays dividend $0.46","DailyReturn":"1.09%","FiveDayReturnAfter":"6.45%","FiveDayReturnBefore":"6.52%"},{"Ticker":"NOV","EffectiveDate":"2016-02-24","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":"-1.43%","FiveDayReturnAfter":"2.95%","FiveDayReturnBefore":"2.08%"},{"Ticker":"NOV","EffectiveDate":"2016-02-24","Type":"Item_5.02","Title":"Change of exectives and board members.\r\n","DailyReturn":"-1.43%","FiveDayReturnAfter":"2.95%","FiveDayReturnBefore":"2.08%"},{"Ticker":"NOV","EffectiveDate":"2016-02-04","Type":"RatingNeutral","Title":"Jefferies maintains NOV to Hold. Target Price is $27; previously $34.","DailyReturn":"2.07%","FiveDayReturnAfter":"-4.79%","FiveDayReturnBefore":"-10.5%"},{"Ticker":"NOV","EffectiveDate":"2016-02-04","Type":"RatingNeutral","Title":"Barclays maintains NOV to Overweight. Target Price is $33; previously $44.","DailyReturn":"2.07%","FiveDayReturnAfter":"-4.79%","FiveDayReturnBefore":"-10.5%"},{"Ticker":"NOV","EffectiveDate":"2016-02-04","Type":"RatingNeutral","Title":"Citigroup maintains NOV to Neutral. Target Price is $30; previously $32.","DailyReturn":"2.07%","FiveDayReturnAfter":"-4.79%","FiveDayReturnBefore":"-10.5%"},{"Ticker":"NOV","EffectiveDate":"2016-02-03","Type":"Item_2.02","Title":"Release results of operational and financial condition\r\n","DailyReturn":"-8.7%","FiveDayReturnAfter":"-10.69%","FiveDayReturnBefore":"0.78%"},{"Ticker":"NOV","EffectiveDate":"2016-02-03","Type":"EarningsRevenueMiss","Title":"Before market open, NOV reports 2015 Q4's earning $0.4 per share and revenue $2722MM. This misses analyst's estimated EPS $0.44, misses estimated revenue $3030MM.","DailyReturn":"-8.7%","FiveDayReturnAfter":"-10.69%","FiveDayReturnBefore":"0.78%"},{"Ticker":"NOV","EffectiveDate":"2016-02-03","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":"-8.7%","FiveDayReturnAfter":"-10.69%","FiveDayReturnBefore":"0.78%"},{"Ticker":"NOV","EffectiveDate":"2016-01-12","Type":"RatingNeutral","Title":"Oppenheimer initiates coverage on NOV to Perform.","DailyReturn":"1.6%","FiveDayReturnAfter":"-1.41%","FiveDayReturnBefore":"-14.46%"},{"Ticker":"NOV","EffectiveDate":"2016-01-05","Type":"RatingNeutral","Title":"GMP Securities initiates coverage on NOV to Hold. Target Price is $34.","DailyReturn":"-2.86%","FiveDayReturnAfter":"-14.46%","FiveDayReturnBefore":"-0.54%"},{"Ticker":"NOV","EffectiveDate":"2016-01-05","Type":"RatingNeutral","Title":"KeyBanc downgrades NOV to Sector Weight from Overweight.","DailyReturn":"-2.86%","FiveDayReturnAfter":"-14.46%","FiveDayReturnBefore":"-0.54%"},{"Ticker":"NOV","EffectiveDate":"2015-12-28","Type":"Item_8.01","Title":"Other 8-K Events\r\n","DailyReturn":"-1.86%","FiveDayReturnAfter":"-0.54%","FiveDayReturnBefore":"3.3%"},{"Ticker":"NOV","EffectiveDate":"2015-12-18","Type":"RatingNeutral","Title":"William Blair downgrades NOV to Market Perform from Outperform.","DailyReturn":"-1.18%","FiveDayReturnAfter":"3.3%","FiveDayReturnBefore":"-0.38%"},{"Ticker":"NOV","EffectiveDate":"2015-12-14","Type":"RatingNeutral","Title":"KLR Group initiates coverage on NOV to Buy. Target Price is $52.","DailyReturn":"0.81%","FiveDayReturnAfter":"-0.06%","FiveDayReturnBefore":"-9.45%"},{"Ticker":"NOV","EffectiveDate":"2015-12-11","Type":"RatingUpgrade","Title":"Citigroup upgrades NOV to Neutral from Sell. Target Price is $34.","DailyReturn":"-1.5%","FiveDayReturnAfter":"-0.38%","FiveDayReturnBefore":"-9.18%"},{"Ticker":"NOV","EffectiveDate":"2015-12-02","Type":"Dividend","Title":"The Firm pays dividend $0.46","DailyReturn":"-0.48%","FiveDayReturnAfter":"-10.63%","FiveDayReturnBefore":"1.03%"},{"Ticker":"NOV","EffectiveDate":"2015-11-30","Type":"RatingUpgrade","Title":"Guggenheim upgrades NOV to Buy from Neutral.","DailyReturn":"-0.02%","FiveDayReturnAfter":"-0.82%","FiveDayReturnBefore":"-0.66%"},{"Ticker":"NOV","EffectiveDate":"2015-11-02","Type":"Item_5.02","Title":"Change of exectives and board members.\r\n","DailyReturn":"3.21%","FiveDayReturnAfter":"5.55%","FiveDayReturnBefore":"-3.06%"},{"Ticker":"NOV","EffectiveDate":"2015-11-02","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":"3.21%","FiveDayReturnAfter":"5.55%","FiveDayReturnBefore":"-3.06%"},{"Ticker":"NOV","EffectiveDate":"2015-10-29","Type":"RatingNeutral","Title":"Barclays maintains NOV to Overweight. Target Price is $44; previously $48.","DailyReturn":"-0.76%","FiveDayReturnAfter":"8.28%","FiveDayReturnBefore":"-6.53%"},{"Ticker":"NOV","EffectiveDate":"2015-10-28","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":"2.14%","FiveDayReturnAfter":"10.52%","FiveDayReturnBefore":"-9.21%"},{"Ticker":"NOV","EffectiveDate":"2015-10-28","Type":"Item_2.02","Title":"Release results of operational and financial condition\r\n","DailyReturn":"2.14%","FiveDayReturnAfter":"10.52%","FiveDayReturnBefore":"-9.21%"},{"Ticker":"NOV","EffectiveDate":"2015-10-05","Type":"RatingNeutral","Title":"Citigroup maintains NOV to Sell. Target Price is $32; previously $37.","DailyReturn":"4.86%","FiveDayReturnAfter":"6.97%","FiveDayReturnBefore":"1.58%"},{"Ticker":"NOV","EffectiveDate":"2015-09-11","Type":"Item_5.02","Title":"Change of exectives and board members.\r\n","DailyReturn":"-1.55%","FiveDayReturnAfter":"0.81%","FiveDayReturnBefore":"-2.88%"},{"Ticker":"NOV","EffectiveDate":"2015-09-09","Type":"Dividend","Title":"The Firm pays dividend $0.46","DailyReturn":"-3.38%","FiveDayReturnAfter":"-3.75%","FiveDayReturnBefore":"-4.12%"},{"Ticker":"NOV","EffectiveDate":"2015-09-04","Type":"RatingNeutral","Title":"Credit Suisse maintains NOV to Underperform. Target Price is $33; previously $39.","DailyReturn":"-1.29%","FiveDayReturnAfter":"-4.71%","FiveDayReturnBefore":"-0.94%"},{"Ticker":"NOV","EffectiveDate":"2015-08-31","Type":"Item_5.02","Title":"Change of exectives and board members.\r\n","DailyReturn":"1.63%","FiveDayReturnAfter":"-2.94%","FiveDayReturnBefore":"11.27%"},{"Ticker":"NOV","EffectiveDate":"2015-08-31","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":"1.63%","FiveDayReturnAfter":"-2.94%","FiveDayReturnBefore":"11.27%"},{"Ticker":"NOV","EffectiveDate":"2015-08-26","Type":"RatingUpgrade","Title":"JP Morgan upgrades NOV to Neutral from Underweight.","DailyReturn":"4.49%","FiveDayReturnAfter":"10.17%","FiveDayReturnBefore":"-6.17%"},{"Ticker":"NOV","EffectiveDate":"2015-08-05","Type":"RatingNeutral","Title":"Argus Research downgrades NOV to Hold from Buy.","DailyReturn":"-0.66%","FiveDayReturnAfter":"-0.39%","FiveDayReturnBefore":"-5.45%"},{"Ticker":"NOV","EffectiveDate":"2015-07-31","Type":"RatingNeutral","Title":"Bank of America downgrades NOV to Neutral from Buy.","DailyReturn":"-2.9%","FiveDayReturnAfter":"-6.64%","FiveDayReturnBefore":"1.08%"},{"Ticker":"NOV","EffectiveDate":"2015-07-28","Type":"Item_2.02","Title":"Release results of operational and financial condition\r\n","DailyReturn":"3.07%","FiveDayReturnAfter":"-1.64%","FiveDayReturnBefore":"-3.49%"},{"Ticker":"NOV","EffectiveDate":"2015-07-28","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":"3.07%","FiveDayReturnAfter":"-1.64%","FiveDayReturnBefore":"-3.49%"},{"Ticker":"NOV","EffectiveDate":"2015-07-17","Type":"RatingNeutral","Title":"UBS downgrades NOV to Sell.","DailyReturn":"-1.1%","FiveDayReturnAfter":"-1.31%","FiveDayReturnBefore":"-2.47%"},{"Ticker":"NOV","EffectiveDate":"2015-07-08","Type":"RatingNeutral","Title":"Citigroup maintains NOV to Sell. Target Price is $41; previously $45.","DailyReturn":"-2.23%","FiveDayReturnAfter":"0.77%","FiveDayReturnBefore":"-7.25%"},{"Ticker":"NOV","EffectiveDate":"2015-06-10","Type":"Dividend","Title":"The Firm pays dividend $0.46","DailyReturn":"3.7%","FiveDayReturnAfter":"2.68%","FiveDayReturnBefore":"-4.68%"},{"Ticker":"NOV","EffectiveDate":"2015-05-29","Type":"RatingNeutral","Title":"JP Morgan initiates coverage on NOV to Underweight. Target Price is $40.","DailyReturn":"-1.4%","FiveDayReturnAfter":"-2.55%","FiveDayReturnBefore":"-0.55%"},{"Ticker":"NOV","EffectiveDate":"2015-05-13","Type":"Item_5.07","Title":"Submission of Matters to a Vote of Security Holders\r\n","DailyReturn":"0.77%","FiveDayReturnAfter":"-2.99%","FiveDayReturnBefore":"-7.33%"},{"Ticker":"NOV","EffectiveDate":"2015-05-12","Type":"Item_2.03","Title":"Issue new debts or other obligations.\r\n","DailyReturn":"0.29%","FiveDayReturnAfter":"-0.29%","FiveDayReturnBefore":"-6.43%"},{"Ticker":"NOV","EffectiveDate":"2015-05-12","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":"0.29%","FiveDayReturnAfter":"-0.29%","FiveDayReturnBefore":"-6.43%"},{"Ticker":"NOV","EffectiveDate":"2015-05-12","Type":"Item_1.01","Title":"Entry into a Material Definitive Agreement\r\n","DailyReturn":"0.29%","FiveDayReturnAfter":"-0.29%","FiveDayReturnBefore":"-6.43%"},{"Ticker":"NOV","EffectiveDate":"2015-05-11","Type":"RatingNeutral","Title":"Citigroup downgrades NOV to Sell from Neutral. Target Price is $45; previously $53.","DailyReturn":"-3.56%","FiveDayReturnAfter":"-3.75%","FiveDayReturnBefore":"-2.77%"},{"Ticker":"NOV","EffectiveDate":"2015-04-29","Type":"RatingNeutral","Title":"Morgan Stanley downgrades NOV to Underweight from Equal-Weight. Target Price is $53.","DailyReturn":"1.9%","FiveDayReturnAfter":"6.46%","FiveDayReturnBefore":"-2.28%"},{"Ticker":"NOV","EffectiveDate":"2015-04-28","Type":"Item_2.02","Title":"Release results of operational and financial condition\r\n","DailyReturn":"-5.04%","FiveDayReturnAfter":"0.09%","FiveDayReturnBefore":"-0.61%"},{"Ticker":"NOV","EffectiveDate":"2015-04-28","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":"-5.04%","FiveDayReturnAfter":"0.09%","FiveDayReturnBefore":"-0.61%"},{"Ticker":"NOV","EffectiveDate":"2015-04-21","Type":"Item_5.02","Title":"Change of exectives and board members.\r\n","DailyReturn":"-3.45%","FiveDayReturnAfter":"-0.61%","FiveDayReturnBefore":"3.41%"},{"Ticker":"NOV","EffectiveDate":"2015-04-21","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":"-3.45%","FiveDayReturnAfter":"-0.61%","FiveDayReturnBefore":"3.41%"},{"Ticker":"NOV","EffectiveDate":"2015-03-11","Type":"Dividend","Title":"The Firm pays dividend $0.46","DailyReturn":"-0.11%","FiveDayReturnAfter":"-5.65%","FiveDayReturnBefore":"-7.15%"},{"Ticker":"NOV","EffectiveDate":"2015-02-18","Type":"RatingNeutral","Title":"BMO Capital initiates coverage on NOV to Underperform. Target Price is $52.","DailyReturn":"1.28%","FiveDayReturnAfter":"-0.81%","FiveDayReturnBefore":"4.35%"},{"Ticker":"NOV","EffectiveDate":"2015-02-04","Type":"RatingNeutral","Title":"Clarksons Platou downgrades NOV to Hold from Buy.","DailyReturn":"-3.23%","FiveDayReturnAfter":"-3.25%","FiveDayReturnBefore":"-6.47%"},{"Ticker":"NOV","EffectiveDate":"2015-02-04","Type":"RatingNeutral","Title":"Sterne Agee downgrades NOV to Neutral from Buy.","DailyReturn":"-3.23%","FiveDayReturnAfter":"-3.25%","FiveDayReturnBefore":"-6.47%"},{"Ticker":"NOV","EffectiveDate":"2015-02-04","Type":"RatingNeutral","Title":"Susquehanna downgrades NOV to Neutral from Positive.","DailyReturn":"-3.23%","FiveDayReturnAfter":"-3.25%","FiveDayReturnBefore":"-6.47%"},{"Ticker":"NOV","EffectiveDate":"2015-02-04","Type":"RatingNeutral","Title":"UBS maintains NOV to Neutral. Target Price is $58; previously $72.","DailyReturn":"-3.23%","FiveDayReturnAfter":"-3.25%","FiveDayReturnBefore":"-6.47%"},{"Ticker":"NOV","EffectiveDate":"2015-02-03","Type":"Item_2.02","Title":"Release results of operational and financial condition\r\n","DailyReturn":"-4.09%","FiveDayReturnAfter":"-6.61%","FiveDayReturnBefore":"-2.36%"},{"Ticker":"NOV","EffectiveDate":"2015-02-03","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":"-4.09%","FiveDayReturnAfter":"-6.61%","FiveDayReturnBefore":"-2.36%"},{"Ticker":"NOV","EffectiveDate":"2015-02-02","Type":"RatingNeutral","Title":"Raymond James downgrades NOV to Outperform from Strong Buy. Target Price is $61; previously $70.","DailyReturn":"3.6%","FiveDayReturnAfter":"-5.66%","FiveDayReturnBefore":"-4.87%"},{"Ticker":"NOV","EffectiveDate":"2015-02-02","Type":"RatingNeutral","Title":"Jefferies maintains NOV to Hold. Target Price is $59; previously $73.","DailyReturn":"3.6%","FiveDayReturnAfter":"-5.66%","FiveDayReturnBefore":"-4.87%"},{"Ticker":"NOV","EffectiveDate":"2015-01-28","Type":"RatingNeutral","Title":"Credit Suisse downgrades NOV to Underperform from Neutral. Target Price is $43; previously $60.","DailyReturn":"-7.22%","FiveDayReturnAfter":"-6.47%","FiveDayReturnBefore":"-1.05%"},{"Ticker":"NOV","EffectiveDate":"2015-01-26","Type":"RatingNeutral","Title":"Guggenheim downgrades NOV to Neutral from Buy; previously $80.","DailyReturn":"1.03%","FiveDayReturnAfter":"-4.87%","FiveDayReturnBefore":"0.63%"},{"Ticker":"NOV","EffectiveDate":"2015-01-09","Type":"RatingNeutral","Title":"Citigroup maintains NOV to Neutral. Target Price is $62; previously $76.","DailyReturn":"-2.75%","FiveDayReturnAfter":"-11.37%","FiveDayReturnBefore":"-2.94%"},{"Ticker":"NOV","EffectiveDate":"2015-01-06","Type":"RatingNeutral","Title":"Societe Generale downgrades NOV to Hold from Buy.","DailyReturn":"-1.23%","FiveDayReturnAfter":"-6.44%","FiveDayReturnBefore":"-6.5%"},{"Ticker":"NOV","EffectiveDate":"2014-12-23","Type":"RatingUpgrade","Title":"Seaport Global upgrades NOV to Accumulate from Neutral. Target Price is $74.","DailyReturn":"0.3%","FiveDayReturnAfter":"-0.04%","FiveDayReturnBefore":"6.78%"},{"Ticker":"NOV","EffectiveDate":"2014-12-03","Type":"Dividend","Title":"The Firm pays dividend $0.46","DailyReturn":"2.17%","FiveDayReturnAfter":"-1.84%","FiveDayReturnBefore":"-9.92%"},{"Ticker":"NOV","EffectiveDate":"2014-11-24","Type":"RatingNeutral","Title":"Credit Suisse maintains NOV to Neutral. Target Price is $75; previously $77.","DailyReturn":"-0.36%","FiveDayReturnAfter":"-10.5%","FiveDayReturnBefore":"3.41%"},{"Ticker":"NOV","EffectiveDate":"2014-11-24","Type":"RatingNeutral","Title":"Credit Suisse maintains NOV to Neutral. Target Price is $75; previously $77.","DailyReturn":"-0.36%","FiveDayReturnAfter":"-10.5%","FiveDayReturnBefore":"3.41%"},{"Ticker":"NOV","EffectiveDate":"2014-11-20","Type":"Item_5.02","Title":"Change of exectives and board members.\r\n","DailyReturn":"1.21%","FiveDayReturnAfter":"-0.28%","FiveDayReturnBefore":"-2.09%"},{"Ticker":"NOV","EffectiveDate":"2014-11-20","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":"1.21%","FiveDayReturnAfter":"-0.28%","FiveDayReturnBefore":"-2.09%"},{"Ticker":"NOV","EffectiveDate":"2014-11-05","Type":"RatingNeutral","Title":"FBR Capital maintains NOV to Outperform. Target Price is $88; previously $100.","DailyReturn":"3.5%","FiveDayReturnAfter":"5.56%","FiveDayReturnBefore":"-5.54%"},{"Ticker":"NOV","EffectiveDate":"2014-11-03","Type":"RatingNeutral","Title":"Credit Suisse downgrades NOV to Neutral from Outperform. Target Price is $77; previously $95.","DailyReturn":"-2.64%","FiveDayReturnAfter":"0.84%","FiveDayReturnBefore":"-1.2%"},{"Ticker":"NOV","EffectiveDate":"2014-11-03","Type":"RatingNeutral","Title":"Cowen & Co. downgrades NOV to Market Perform from Outperform.","DailyReturn":"-2.64%","FiveDayReturnAfter":"0.84%","FiveDayReturnBefore":"-1.2%"},{"Ticker":"NOV","EffectiveDate":"2014-10-30","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":"-2.7%","FiveDayReturnAfter":"-1.62%","FiveDayReturnBefore":"1.78%"},{"Ticker":"NOV","EffectiveDate":"2014-10-30","Type":"Item_2.02","Title":"Release results of operational and financial condition\r\n","DailyReturn":"-2.7%","FiveDayReturnAfter":"-1.62%","FiveDayReturnBefore":"1.78%"},{"Ticker":"NOV","EffectiveDate":"2014-10-16","Type":"RatingNeutral","Title":"ISI Group initiates coverage on NOV to Buy. Target Price is $95.","DailyReturn":"1.77%","FiveDayReturnAfter":"2.07%","FiveDayReturnBefore":"-5.5%"},{"Ticker":"NOV","EffectiveDate":"2014-10-08","Type":"RatingNeutral","Title":"HSBC downgrades NOV to Neutral from Overweight. Target Price is $80; previously $89.22.","DailyReturn":"0.32%","FiveDayReturnAfter":"-7.3%","FiveDayReturnBefore":"-3.21%"},{"Ticker":"NOV","EffectiveDate":"2014-10-02","Type":"RatingUpgrade","Title":"Standpoint upgrades NOV to Buy from Hold.","DailyReturn":"-0.46%","FiveDayReturnAfter":"-0.82%","FiveDayReturnBefore":"-5.63%"},{"Ticker":"NOV","EffectiveDate":"2014-09-30","Type":"Item_8.01","Title":"Other 8-K Events\r\n","DailyReturn":"-2.56%","FiveDayReturnAfter":"-6.01%","FiveDayReturnBefore":"-0.76%"},{"Ticker":"NOV","EffectiveDate":"2014-09-30","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":"-2.56%","FiveDayReturnAfter":"-6.01%","FiveDayReturnBefore":"-0.76%"},{"Ticker":"NOV","EffectiveDate":"2014-09-24","Type":"RatingNeutral","Title":"Wells Fargo initiates coverage on NOV to Market Perform.","DailyReturn":"0.05%","FiveDayReturnAfter":"-3.51%","FiveDayReturnBefore":"-4.38%"},{"Ticker":"NOV","EffectiveDate":"2014-09-10","Type":"Dividend","Title":"The Firm pays dividend $0.46","DailyReturn":"0.24%","FiveDayReturnAfter":"1.29%","FiveDayReturnBefore":"-3.46%"},{"Ticker":"NOV","EffectiveDate":"2014-08-18","Type":"Item_5.02","Title":"Change of exectives and board members.\r\n","DailyReturn":"0.46%","FiveDayReturnAfter":"2.27%","FiveDayReturnBefore":"-0.24%"},{"Ticker":"NOV","EffectiveDate":"2014-08-18","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":"0.46%","FiveDayReturnAfter":"2.27%","FiveDayReturnBefore":"-0.24%"},{"Ticker":"NOV","EffectiveDate":"2014-08-14","Type":"Item_2.02","Title":"Release results of operational and financial condition\r\n","DailyReturn":"-1.76%","FiveDayReturnAfter":"1.95%","FiveDayReturnBefore":"0.25%"},{"Ticker":"NOV","EffectiveDate":"2014-08-14","Type":"Item_8.01","Title":"Other 8-K Events\r\n","DailyReturn":"-1.76%","FiveDayReturnAfter":"1.95%","FiveDayReturnBefore":"0.25%"},{"Ticker":"NOV","EffectiveDate":"2014-08-14","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":"-1.76%","FiveDayReturnAfter":"1.95%","FiveDayReturnBefore":"0.25%"},{"Ticker":"NOV","EffectiveDate":"2014-08-14","Type":"Item_2.02","Title":"Release results of operational and financial condition\r\n","DailyReturn":"-1.76%","FiveDayReturnAfter":"1.95%","FiveDayReturnBefore":"0.25%"},{"Ticker":"NOV","EffectiveDate":"2014-08-14","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":"-1.76%","FiveDayReturnAfter":"1.95%","FiveDayReturnBefore":"0.25%"},{"Ticker":"NOV","EffectiveDate":"2014-08-14","Type":"Item_8.01","Title":"Other 8-K Events\r\n","DailyReturn":"-1.76%","FiveDayReturnAfter":"1.95%","FiveDayReturnBefore":"0.25%"},{"Ticker":"NOV","EffectiveDate":"2014-08-01","Type":"Item_5.02","Title":"Change of exectives and board members.\r\n","DailyReturn":"0.06%","FiveDayReturnAfter":"0.73%","FiveDayReturnBefore":"-5.29%"},{"Ticker":"NOV","EffectiveDate":"2014-08-01","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":"0.06%","FiveDayReturnAfter":"0.73%","FiveDayReturnBefore":"-5.29%"},{"Ticker":"NOV","EffectiveDate":"2014-07-30","Type":"RatingNeutral","Title":"Credit Suisse maintains NOV to Outperform. Target Price is $95; previously $90.","DailyReturn":"-2.01%","FiveDayReturnAfter":"-2.24%","FiveDayReturnBefore":"-3.09%"},{"Ticker":"NOV","EffectiveDate":"2014-07-30","Type":"RatingNeutral","Title":"Raymond James maintains NOV to Outperform. Target Price is $98; previously $95.","DailyReturn":"-2.01%","FiveDayReturnAfter":"-2.24%","FiveDayReturnBefore":"-3.09%"},{"Ticker":"NOV","EffectiveDate":"2014-07-30","Type":"RatingNeutral","Title":"Jefferies downgrades NOV to Hold from Buy. Target Price is $91; previously $85.62.","DailyReturn":"-2.01%","FiveDayReturnAfter":"-2.24%","FiveDayReturnBefore":"-3.09%"},{"Ticker":"NOV","EffectiveDate":"2014-07-30","Type":"RatingNeutral","Title":"iBERIA Capital Partners downgrades NOV to Sector Perform from Outperform. Target Price is $88; previously $79.31.","DailyReturn":"-2.01%","FiveDayReturnAfter":"-2.24%","FiveDayReturnBefore":"-3.09%"},{"Ticker":"NOV","EffectiveDate":"2014-07-29","Type":"Item_2.02","Title":"Release results of operational and financial condition\r\n","DailyReturn":"-1.52%","FiveDayReturnAfter":"-2.18%","FiveDayReturnBefore":"-1.03%"},{"Ticker":"NOV","EffectiveDate":"2014-07-29","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":"-1.52%","FiveDayReturnAfter":"-2.18%","FiveDayReturnBefore":"-1.03%"},{"Ticker":"NOV","EffectiveDate":"2014-07-24","Type":"RatingNeutral","Title":"Standpoint Research downgrades NOV to Hold from Buy.","DailyReturn":"-0.84%","FiveDayReturnAfter":"-5.3%","FiveDayReturnBefore":"0.95%"},{"Ticker":"NOV","EffectiveDate":"2014-06-25","Type":"RatingNeutral","Title":"Gabelli & Co. initiates coverage on NOV to Buy.","DailyReturn":"1.58%","FiveDayReturnAfter":"3.54%","FiveDayReturnBefore":"2.05%"},{"Ticker":"NOV","EffectiveDate":"2014-06-18","Type":"RatingNeutral","Title":"JP Morgan maintains NOV to Overweight. Target Price is $87; previously $94.","DailyReturn":"0.06%","FiveDayReturnAfter":"2.05%","FiveDayReturnBefore":"-0.1%"},{"Ticker":"NOV","EffectiveDate":"2014-06-12","Type":"RatingUpgrade","Title":"Societe Generale upgrades NOV to Buy from Hold.","DailyReturn":"0.89%","FiveDayReturnAfter":"2.06%","FiveDayReturnBefore":"0.67%"},{"Ticker":"NOV","EffectiveDate":"2014-06-11","Type":"Dividend","Title":"The Firm pays dividend $0.46","DailyReturn":"-2.07%","FiveDayReturnAfter":"-0.1%","FiveDayReturnBefore":"3.15%"},{"Ticker":"NOV","EffectiveDate":"2014-06-10","Type":"Item_2.02","Title":"Release results of operational and financial condition\r\n","DailyReturn":"0.51%","FiveDayReturnAfter":"0.3%","FiveDayReturnBefore":"5.08%"},{"Ticker":"NOV","EffectiveDate":"2014-06-10","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":"0.51%","FiveDayReturnAfter":"0.3%","FiveDayReturnBefore":"5.08%"},{"Ticker":"NOV","EffectiveDate":"2014-06-05","Type":"RatingNeutral","Title":"Raymond James maintains NOV to Outperform. Target Price is $85; previously $90.","DailyReturn":"-0.07%","FiveDayReturnAfter":"0.67%","FiveDayReturnBefore":"3.31%"},{"Ticker":"NOV","EffectiveDate":"2014-06-05","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":"-0.07%","FiveDayReturnAfter":"0.67%","FiveDayReturnBefore":"3.31%"},{"Ticker":"NOV","EffectiveDate":"2014-06-05","Type":"RatingNeutral","Title":"Credit Suisse assumes NOV to Outperform. Target Price is $90.","DailyReturn":"-0.07%","FiveDayReturnAfter":"0.67%","FiveDayReturnBefore":"3.31%"},{"Ticker":"NOV","EffectiveDate":"2014-06-05","Type":"Item_2.01","Title":"Completion of Acquisition or Disposition of Assets\r\n","DailyReturn":"-0.07%","FiveDayReturnAfter":"0.67%","FiveDayReturnBefore":"3.31%"},{"Ticker":"NOV","EffectiveDate":"2014-05-30","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":"-0.25%","FiveDayReturnAfter":"2.97%","FiveDayReturnBefore":"-0.34%"},{"Ticker":"NOV","EffectiveDate":"2014-05-30","Type":"Item_5.02","Title":"Change of exectives and board members.\r\n","DailyReturn":"-0.25%","FiveDayReturnAfter":"2.97%","FiveDayReturnBefore":"-0.34%"},{"Ticker":"NOV","EffectiveDate":"2014-05-30","Type":"Item_8.01","Title":"Other 8-K Events\r\n","DailyReturn":"-0.25%","FiveDayReturnAfter":"2.97%","FiveDayReturnBefore":"-0.34%"},{"Ticker":"NOV","EffectiveDate":"2014-05-14","Type":"Item_5.07","Title":"Submission of Matters to a Vote of Security Holders\r\n","DailyReturn":"-0.36%","FiveDayReturnAfter":"0.9%","FiveDayReturnBefore":"1.56%"},{"Ticker":"NOV","EffectiveDate":"2014-05-12","Type":"Item_8.01","Title":"Other 8-K Events\r\n","DailyReturn":"0.51%","FiveDayReturnAfter":"2%","FiveDayReturnBefore":"0.76%"},{"Ticker":"NOV","EffectiveDate":"2014-05-12","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":"0.51%","FiveDayReturnAfter":"2%","FiveDayReturnBefore":"0.76%"},{"Ticker":"NOV","EffectiveDate":"2014-05-01","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":"0.34%","FiveDayReturnAfter":"2.7%","FiveDayReturnBefore":"-5.11%"},{"Ticker":"NOV","EffectiveDate":"2014-05-01","Type":"Item_8.01","Title":"Other 8-K Events\r\n","DailyReturn":"0.34%","FiveDayReturnAfter":"2.7%","FiveDayReturnBefore":"-5.11%"},{"Ticker":"NOV","EffectiveDate":"2014-04-29","Type":"RatingNeutral","Title":"Seaport Global downgrades NOV to Neutral from Buy. Target Price is $80; previously $90.","DailyReturn":"1.03%","FiveDayReturnAfter":"3.27%","FiveDayReturnBefore":"-6.42%"},{"Ticker":"NOV","EffectiveDate":"2014-04-29","Type":"RatingNeutral","Title":"Citigroup maintains NOV to Buy. Target Price is $96; previously $101.","DailyReturn":"1.03%","FiveDayReturnAfter":"3.27%","FiveDayReturnBefore":"-6.42%"},{"Ticker":"NOV","EffectiveDate":"2014-04-28","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":"-7.37%","FiveDayReturnAfter":"-4.99%","FiveDayReturnBefore":"1.32%"},{"Ticker":"NOV","EffectiveDate":"2014-04-28","Type":"Item_2.02","Title":"Release results of operational and financial condition\r\n","DailyReturn":"-7.37%","FiveDayReturnAfter":"-4.99%","FiveDayReturnBefore":"1.32%"},{"Ticker":"NOV","EffectiveDate":"2014-04-15","Type":"RatingNeutral","Title":"Bank of America maintains NOV to Buy. Target Price is $85; previously $93.","DailyReturn":"1.5%","FiveDayReturnAfter":"3.36%","FiveDayReturnBefore":"2.96%"},{"Ticker":"NOV","EffectiveDate":"2014-04-08","Type":"Item_5.02","Title":"Change of exectives and board members.\r\n","DailyReturn":"1.2%","FiveDayReturnAfter":"2.96%","FiveDayReturnBefore":"-0.87%"},{"Ticker":"NOV","EffectiveDate":"2014-04-08","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":"1.2%","FiveDayReturnAfter":"2.96%","FiveDayReturnBefore":"-0.87%"},{"Ticker":"NOV","EffectiveDate":"2014-04-04","Type":"RatingUpgrade","Title":"Standpoint Research upgrades NOV to Buy from Hold.","DailyReturn":"1.02%","FiveDayReturnAfter":"0.57%","FiveDayReturnBefore":"2.76%"},{"Ticker":"NOV","EffectiveDate":"2014-03-17","Type":"RatingNeutral","Title":"Goldman Sachs downgrades NOV to Neutral from Buy.","DailyReturn":"-0.71%","FiveDayReturnAfter":"-0.17%","FiveDayReturnBefore":"-5.47%"},{"Ticker":"NOV","EffectiveDate":"2014-03-13","Type":"RatingNeutral","Title":"ISI Group downgrades NOV to Neutral from Buy.","DailyReturn":"-2.75%","FiveDayReturnAfter":"-4.38%","FiveDayReturnBefore":"0.11%"},{"Ticker":"NOV","EffectiveDate":"2014-03-12","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":"-0.65%","FiveDayReturnAfter":"-4.64%","FiveDayReturnBefore":"0.3%"},{"Ticker":"NOV","EffectiveDate":"2014-03-12","Type":"Dividend","Title":"The Firm pays dividend $0.23445","DailyReturn":"-0.65%","FiveDayReturnAfter":"-4.64%","FiveDayReturnBefore":"0.3%"},{"Ticker":"NOV","EffectiveDate":"2014-03-12","Type":"Item_8.01","Title":"Other 8-K Events\r\n","DailyReturn":"-0.65%","FiveDayReturnAfter":"-4.64%","FiveDayReturnBefore":"0.3%"},{"Ticker":"NOV","EffectiveDate":"2014-02-27","Type":"Item_5.02","Title":"Change of exectives and board members.\r\n","DailyReturn":"0.48%","FiveDayReturnAfter":"4.13%","FiveDayReturnBefore":"-2.81%"},{"Ticker":"NOV","EffectiveDate":"2014-02-27","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":"0.48%","FiveDayReturnAfter":"4.13%","FiveDayReturnBefore":"-2.81%"},{"Ticker":"NOV","EffectiveDate":"2014-01-31","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":"1.84%","FiveDayReturnAfter":"0.55%","FiveDayReturnBefore":"-3.29%"},{"Ticker":"NOV","EffectiveDate":"2014-01-31","Type":"Item_2.02","Title":"Release results of operational and financial condition\r\n","DailyReturn":"1.84%","FiveDayReturnAfter":"0.55%","FiveDayReturnBefore":"-3.29%"},{"Ticker":"NOV","EffectiveDate":"2014-01-08","Type":"RatingNeutral","Title":"RBC Capital downgrades NOV to Sector Perform from Outperform. Target Price is $86.","DailyReturn":"-2.05%","FiveDayReturnAfter":"-2.89%","FiveDayReturnBefore":"1.42%"},{"Ticker":"NOV","EffectiveDate":"2014-01-08","Type":"RatingNeutral","Title":"RBC Capital downgrades NOV to Sector Perform from Outperform. Target Price is $86.","DailyReturn":"-2.05%","FiveDayReturnAfter":"-2.89%","FiveDayReturnBefore":"1.42%"},{"Ticker":"NOV","EffectiveDate":"2013-12-04","Type":"Dividend","Title":"The Firm pays dividend $0.23445","DailyReturn":"-0.61%","FiveDayReturnAfter":"-3.98%","FiveDayReturnBefore":"0.01%"},{"Ticker":"NOV","EffectiveDate":"2013-11-25","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":"-1.25%","FiveDayReturnAfter":"-2.38%","FiveDayReturnBefore":"-0.76%"},{"Ticker":"NOV","EffectiveDate":"2013-11-25","Type":"Item_8.01","Title":"Other 8-K Events\r\n","DailyReturn":"-1.25%","FiveDayReturnAfter":"-2.38%","FiveDayReturnBefore":"-0.76%"},{"Ticker":"NOV","EffectiveDate":"2013-11-14","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":"1.38%","FiveDayReturnAfter":"1.13%","FiveDayReturnBefore":"1.24%"},{"Ticker":"NOV","EffectiveDate":"2013-11-14","Type":"Item_5.02","Title":"Change of exectives and board members.\r\n","DailyReturn":"1.38%","FiveDayReturnAfter":"1.13%","FiveDayReturnBefore":"1.24%"},{"Ticker":"NOV","EffectiveDate":"2013-10-25","Type":"EarningsRevenueBeat","Title":"Before market open, NOV reports 2013 Q3's earning $1.34 per share and revenue $5690MM. This beats analyst's estimated EPS $1.32, beats estimated revenue $5680MM.","DailyReturn":"4.53%","FiveDayReturnAfter":"2.55%","FiveDayReturnBefore":"-2.32%"},{"Ticker":"NOV","EffectiveDate":"2013-10-25","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":"4.53%","FiveDayReturnAfter":"2.55%","FiveDayReturnBefore":"-2.32%"},{"Ticker":"NOV","EffectiveDate":"2013-10-25","Type":"Item_2.02","Title":"Release results of operational and financial condition\r\n","DailyReturn":"4.53%","FiveDayReturnAfter":"2.55%","FiveDayReturnBefore":"-2.32%"},{"Ticker":"NOV","EffectiveDate":"2013-10-15","Type":"RatingNeutral","Title":"Baird initiates coverage on NOV to Neutral. Target Price is $82.","DailyReturn":"-0.16%","FiveDayReturnAfter":"2.21%","FiveDayReturnBefore":"1.91%"},{"Ticker":"NOV","EffectiveDate":"2013-10-07","Type":"RatingNeutral","Title":"Clarksons Platou initiates coverage on NOV to Outperform. Target Price is $96.","DailyReturn":"-1.23%","FiveDayReturnAfter":"-0.27%","FiveDayReturnBefore":"1.94%"},{"Ticker":"NOV","EffectiveDate":"2013-09-24","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":"0.22%","FiveDayReturnAfter":"-0.49%","FiveDayReturnBefore":"-0.29%"},{"Ticker":"NOV","EffectiveDate":"2013-09-24","Type":"Item_7.01","Title":"Fair disclosure\r\n","DailyReturn":"0.22%","FiveDayReturnAfter":"-0.49%","FiveDayReturnBefore":"-0.29%"},{"Ticker":"NOV","EffectiveDate":"2013-09-16","Type":"RatingNeutral","Title":"Jefferies maintains NOV to Buy. Target Price is $91; previously $84.","DailyReturn":"0.62%","FiveDayReturnAfter":"0.72%","FiveDayReturnBefore":"0.62%"},{"Ticker":"NOV","EffectiveDate":"2013-09-11","Type":"Dividend","Title":"The Firm pays dividend $0.23445","DailyReturn":"0.45%","FiveDayReturnAfter":"0.67%","FiveDayReturnBefore":"3.82%"},{"Ticker":"NOV","EffectiveDate":"2013-09-10","Type":"RatingUpgrade","Title":"Credit Suisse upgrades NOV to Outperform from Neutral. Target Price is $90; previously $82.","DailyReturn":"0.26%","FiveDayReturnAfter":"0.72%","FiveDayReturnBefore":"5.39%"},{"Ticker":"NOV","EffectiveDate":"2013-09-10","Type":"RatingUpgrade","Title":"Credit Suisse upgrades NOV to Outperform from Neutral.","DailyReturn":"0.26%","FiveDayReturnAfter":"0.72%","FiveDayReturnBefore":"5.39%"},{"Ticker":"NOV","EffectiveDate":"2013-09-09","Type":"RatingNeutral","Title":"Standpoint Research downgrades NOV to Hold from Buy.","DailyReturn":"0.52%","FiveDayReturnAfter":"0.62%","FiveDayReturnBefore":"4.83%"},{"Ticker":"NOV","EffectiveDate":"2013-08-15","Type":"RatingUpgrade","Title":"RBC Capital upgrades NOV to Outperform from Sector Perform. Target Price is $86; previously $78.","DailyReturn":"0.29%","FiveDayReturnAfter":"-3.79%","FiveDayReturnBefore":"1.28%"},{"Ticker":"NOV","EffectiveDate":"2013-07-31","Type":"RatingNeutral","Title":"Societe Generale downgrades NOV to Hold from Buy. Target Price is $77; previously $83.","DailyReturn":"1.1%","FiveDayReturnAfter":"3.78%","FiveDayReturnBefore":"-4.7%"},{"Ticker":"NOV","EffectiveDate":"2013-07-30","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":"-2.44%","FiveDayReturnAfter":"1.09%","FiveDayReturnBefore":"-3.49%"},{"Ticker":"NOV","EffectiveDate":"2013-07-30","Type":"Item_2.02","Title":"Release results of operational and financial condition\r\n","DailyReturn":"-2.44%","FiveDayReturnAfter":"1.09%","FiveDayReturnBefore":"-3.49%"},{"Ticker":"NOV","EffectiveDate":"2013-06-12","Type":"Dividend","Title":"The Firm pays dividend $0.23445","DailyReturn":"0.43%","FiveDayReturnAfter":"3.67%","FiveDayReturnBefore":"-1.04%"},{"Ticker":"NOV","EffectiveDate":"2013-05-22","Type":"Item_5.07","Title":"Submission of Matters to a Vote of Security Holders\r\n","DailyReturn":"-1.78%","FiveDayReturnAfter":"1.6%","FiveDayReturnBefore":"3.45%"},{"Ticker":"NOV","EffectiveDate":"2013-04-29","Type":"RatingNeutral","Title":"BMO Capital maintains NOV to Outperform. Target Price is $88; previously $90.","DailyReturn":"-0.6%","FiveDayReturnAfter":"0.84%","FiveDayReturnBefore":"3.07%"},{"Ticker":"NOV","EffectiveDate":"2013-04-29","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":"-0.6%","FiveDayReturnAfter":"0.84%","FiveDayReturnBefore":"3.07%"},{"Ticker":"NOV","EffectiveDate":"2013-04-29","Type":"RatingNeutral","Title":"Cowen & Co. maintains NOV to Buy. Target Price is $90; previously $95.","DailyReturn":"-0.6%","FiveDayReturnAfter":"0.84%","FiveDayReturnBefore":"3.07%"},{"Ticker":"NOV","EffectiveDate":"2013-04-29","Type":"Item_5.02","Title":"Change of exectives and board members.\r\n","DailyReturn":"-0.6%","FiveDayReturnAfter":"0.84%","FiveDayReturnBefore":"3.07%"},{"Ticker":"NOV","EffectiveDate":"2013-04-26","Type":"EarningsRevenueMiss","Title":"Before market open, NOV reports 2013 Q1's earning $1.29 per share and revenue $5310MM. This misses analyst's estimated EPS $1.37, misses estimated revenue $5390MM.","DailyReturn":"-1.32%","FiveDayReturnAfter":"-2.4%","FiveDayReturnBefore":"3.94%"},{"Ticker":"NOV","EffectiveDate":"2013-04-26","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":"-1.32%","FiveDayReturnAfter":"-2.4%","FiveDayReturnBefore":"3.94%"},{"Ticker":"NOV","EffectiveDate":"2013-04-26","Type":"Item_2.02","Title":"Release results of operational and financial condition\r\n","DailyReturn":"-1.32%","FiveDayReturnAfter":"-2.4%","FiveDayReturnBefore":"3.94%"},{"Ticker":"NOV","EffectiveDate":"2013-03-22","Type":"Item_5.02","Title":"Change of exectives and board members.\r\n","DailyReturn":"0.66%","FiveDayReturnAfter":"4.24%","FiveDayReturnBefore":"-1.43%"},{"Ticker":"NOV","EffectiveDate":"2013-03-22","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":"0.66%","FiveDayReturnAfter":"4.24%","FiveDayReturnBefore":"-1.43%"},{"Ticker":"NOV","EffectiveDate":"2013-03-20","Type":"RatingNeutral","Title":"Citigroup maintains NOV to Buy. Target Price is $85; previously $96.","DailyReturn":"1.04%","FiveDayReturnAfter":"2.09%","FiveDayReturnBefore":"0.78%"},{"Ticker":"NOV","EffectiveDate":"2013-03-13","Type":"Dividend","Title":"The Firm pays dividend $0.11722","DailyReturn":"0.02%","FiveDayReturnAfter":"0.78%","FiveDayReturnBefore":"0.89%"},{"Ticker":"NOV","EffectiveDate":"2013-02-05","Type":"RatingNeutral","Title":"Bernstein downgrades NOV to Market Perform from Outperform. Target Price is $80; previously $85.","DailyReturn":"-2.79%","FiveDayReturnAfter":"-2.75%","FiveDayReturnBefore":"-4.79%"},{"Ticker":"NOV","EffectiveDate":"2013-02-04","Type":"RatingNeutral","Title":"Dahlman Rose maintains NOV to Buy. Target Price is $95; previously $102.","DailyReturn":"-1.52%","FiveDayReturnAfter":"-3.1%","FiveDayReturnBefore":"-3.77%"},{"Ticker":"NOV","EffectiveDate":"2013-02-04","Type":"RatingNeutral","Title":"RS Platou Markets maintains NOV to Buy. Target Price is $87; previously $96.","DailyReturn":"-1.52%","FiveDayReturnAfter":"-3.1%","FiveDayReturnBefore":"-3.77%"},{"Ticker":"NOV","EffectiveDate":"2013-02-04","Type":"RatingNeutral","Title":"BMO Capital maintains NOV to Outperform. Target Price is $90; previously $101.","DailyReturn":"-1.52%","FiveDayReturnAfter":"-3.1%","FiveDayReturnBefore":"-3.77%"},{"Ticker":"NOV","EffectiveDate":"2013-02-04","Type":"RatingNeutral","Title":"Jefferies maintains NOV to Buy. Target Price is $86; previously $90.","DailyReturn":"-1.52%","FiveDayReturnAfter":"-3.1%","FiveDayReturnBefore":"-3.77%"},{"Ticker":"NOV","EffectiveDate":"2013-02-04","Type":"RatingNeutral","Title":"Barclays maintains NOV to Overweight. Target Price is $93; previously $126.","DailyReturn":"-1.52%","FiveDayReturnAfter":"-3.1%","FiveDayReturnBefore":"-3.77%"},{"Ticker":"NOV","EffectiveDate":"2013-02-01","Type":"RatingNeutral","Title":"Credit Suisse initiates coverage on NOV to Neutral. Target Price is $72.","DailyReturn":"-3.88%","FiveDayReturnAfter":"-8.49%","FiveDayReturnBefore":"0.51%"},{"Ticker":"NOV","EffectiveDate":"2013-02-01","Type":"Item_2.02","Title":"Release results of operational and financial condition\r\n","DailyReturn":"-3.88%","FiveDayReturnAfter":"-8.49%","FiveDayReturnBefore":"0.51%"},{"Ticker":"NOV","EffectiveDate":"2013-02-01","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":"-3.88%","FiveDayReturnAfter":"-8.49%","FiveDayReturnBefore":"0.51%"},{"Ticker":"NOV","EffectiveDate":"2013-01-25","Type":"RatingNeutral","Title":"ISI Group downgrades NOV to Buy from Strong Buy. Target Price is $83; previously $105.","DailyReturn":"0.32%","FiveDayReturnAfter":"0.51%","FiveDayReturnBefore":"4.63%"},{"Ticker":"NOV","EffectiveDate":"2013-01-08","Type":"RatingNeutral","Title":"RBC Capital downgrades NOV to Sector Perform from Outperform.","DailyReturn":"-2.73%","FiveDayReturnAfter":"-1.42%","FiveDayReturnBefore":"7.97%"},{"Ticker":"NOV","EffectiveDate":"2012-12-14","Type":"RatingNeutral","Title":"Guggenheim downgrades NOV to Neutral from Buy. Target Price is $71; previously $90.","DailyReturn":"-1.08%","FiveDayReturnAfter":"5.86%","FiveDayReturnBefore":"-3.71%"},{"Ticker":"NOV","EffectiveDate":"2012-12-14","Type":"RatingNeutral","Title":"Guggenheim downgrades NOV to Neutral from Buy.","DailyReturn":"-1.08%","FiveDayReturnAfter":"5.86%","FiveDayReturnBefore":"-3.71%"},{"Ticker":"NOV","EffectiveDate":"2012-12-12","Type":"RatingNeutral","Title":"Credit Agricole downgrades NOV to Outperform from Buy. Target Price is $80; previously $95.","DailyReturn":"-2.22%","FiveDayReturnAfter":"1.05%","FiveDayReturnBefore":"-0.98%"},{"Ticker":"NOV","EffectiveDate":"2012-12-06","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":"-0.8%","FiveDayReturnAfter":"-3.15%","FiveDayReturnBefore":"-2.07%"},{"Ticker":"NOV","EffectiveDate":"2012-12-06","Type":"Item_5.02","Title":"Change of exectives and board members.\r\n","DailyReturn":"-0.8%","FiveDayReturnAfter":"-3.15%","FiveDayReturnBefore":"-2.07%"},{"Ticker":"NOV","EffectiveDate":"2012-12-05","Type":"Dividend","Title":"The Firm pays dividend $0.11722","DailyReturn":"-0.07%","FiveDayReturnAfter":"-0.98%","FiveDayReturnBefore":"-1.77%"},{"Ticker":"NOV","EffectiveDate":"2012-11-16","Type":"RatingUpgrade","Title":"Standpoint Research upgrades NOV to Buy from Hold.","DailyReturn":"0.24%","FiveDayReturnAfter":"3.02%","FiveDayReturnBefore":"1.37%"},{"Ticker":"NOV","EffectiveDate":"2012-11-15","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":"1.27%","FiveDayReturnAfter":"2.9%","FiveDayReturnBefore":"-2.2%"},{"Ticker":"NOV","EffectiveDate":"2012-11-15","Type":"Item_1.01","Title":"Entry into a Material Definitive Agreement\r\n","DailyReturn":"1.27%","FiveDayReturnAfter":"2.9%","FiveDayReturnBefore":"-2.2%"},{"Ticker":"NOV","EffectiveDate":"2012-10-31","Type":"RatingNeutral","Title":"JP Morgan maintains NOV to Overweight. Target Price is $95; previously $103.","DailyReturn":"-1.16%","FiveDayReturnAfter":"-2.15%","FiveDayReturnBefore":"-7.9%"},{"Ticker":"NOV","EffectiveDate":"2012-10-26","Type":"RatingNeutral","Title":"Jefferies maintains NOV to Buy. Target Price is $90; previously $94.","DailyReturn":"-0.41%","FiveDayReturnAfter":"-4.43%","FiveDayReturnBefore":"-9.11%"},{"Ticker":"NOV","EffectiveDate":"2012-10-25","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":"-2.46%","FiveDayReturnAfter":"-6.9%","FiveDayReturnBefore":"-5.62%"},{"Ticker":"NOV","EffectiveDate":"2012-10-25","Type":"EarningsRelease","Title":"Before market open, NOV reports 2012 Q3's earning $1.44 per share and revenue $5319MM..","DailyReturn":"-2.46%","FiveDayReturnAfter":"-6.9%","FiveDayReturnBefore":"-5.62%"},{"Ticker":"NOV","EffectiveDate":"2012-10-25","Type":"Item_2.02","Title":"Release results of operational and financial condition\r\n","DailyReturn":"-2.46%","FiveDayReturnAfter":"-6.9%","FiveDayReturnBefore":"-5.62%"},{"Ticker":"NOV","EffectiveDate":"2012-10-04","Type":"RatingNeutral","Title":"Societe Generale maintains NOV to Buy. Target Price is $93; previously $86.","DailyReturn":"1.06%","FiveDayReturnAfter":"-1.52%","FiveDayReturnBefore":"1.4%"},{"Ticker":"NOV","EffectiveDate":"2012-10-03","Type":"RatingNeutral","Title":"Goldman Sachs assumes NOV to Buy. Target Price is $97.","DailyReturn":"-1.53%","FiveDayReturnAfter":"-0.79%","FiveDayReturnBefore":"0.67%"},{"Ticker":"NOV","EffectiveDate":"2012-09-28","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":"-0.03%","FiveDayReturnAfter":"0.24%","FiveDayReturnBefore":"-0.57%"},{"Ticker":"NOV","EffectiveDate":"2012-09-28","Type":"Item_1.02","Title":"Termination of a Material Definitive Agreement\r\n","DailyReturn":"-0.03%","FiveDayReturnAfter":"0.24%","FiveDayReturnBefore":"-0.57%"},{"Ticker":"NOV","EffectiveDate":"2012-09-28","Type":"Item_1.01","Title":"Entry into a Material Definitive Agreement\r\n","DailyReturn":"-0.03%","FiveDayReturnAfter":"0.24%","FiveDayReturnBefore":"-0.57%"},{"Ticker":"NOV","EffectiveDate":"2012-09-12","Type":"Dividend","Title":"The Firm pays dividend $0.10821","DailyReturn":"0.66%","FiveDayReturnAfter":"-0.3%","FiveDayReturnBefore":"6.28%"},{"Ticker":"NOV","EffectiveDate":"2012-09-07","Type":"RatingNeutral","Title":"RS Platou Markets maintains NOV to Buy. Target Price is $105; previously $100.","DailyReturn":"2.83%","FiveDayReturnAfter":"5.91%","FiveDayReturnBefore":"3.2%"},{"Ticker":"NOV","EffectiveDate":"2012-07-30","Type":"RatingNeutral","Title":"Dahlman Rose maintains NOV to Buy. Target Price is $105; previously $103.","DailyReturn":"0.51%","FiveDayReturnAfter":"2.28%","FiveDayReturnBefore":"6.23%"},{"Ticker":"NOV","EffectiveDate":"2012-07-27","Type":"RatingNeutral","Title":"Citigroup maintains NOV to Buy. Target Price is $96; previously $90.","DailyReturn":"0.47%","FiveDayReturnAfter":"-0.78%","FiveDayReturnBefore":"3.95%"},{"Ticker":"NOV","EffectiveDate":"2012-07-26","Type":"Item_2.02","Title":"Release results of operational and financial condition\r\n","DailyReturn":"8.88%","FiveDayReturnAfter":"9.03%","FiveDayReturnBefore":"-2.46%"},{"Ticker":"NOV","EffectiveDate":"2012-07-26","Type":"RatingNeutral","Title":"Standpoint Research downgrades NOV to Hold from Buy.","DailyReturn":"8.88%","FiveDayReturnAfter":"9.03%","FiveDayReturnBefore":"-2.46%"},{"Ticker":"NOV","EffectiveDate":"2012-07-26","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":"8.88%","FiveDayReturnAfter":"9.03%","FiveDayReturnBefore":"-2.46%"},{"Ticker":"NOV","EffectiveDate":"2012-07-26","Type":"EarningsRelease","Title":"Before market open, NOV reports 2012 Q2's earning $1.42 per share and revenue $4734MM..","DailyReturn":"8.88%","FiveDayReturnAfter":"9.03%","FiveDayReturnBefore":"-2.46%"},{"Ticker":"NOV","EffectiveDate":"2012-06-13","Type":"Dividend","Title":"The Firm pays dividend $0.10821","DailyReturn":"-0.92%","FiveDayReturnAfter":"-0.16%","FiveDayReturnBefore":"1.85%"},{"Ticker":"NOV","EffectiveDate":"2012-05-24","Type":"RatingUpgrade","Title":"Societe Generale upgrades NOV to Buy from Hold. Target Price is $85; previously $92.","DailyReturn":"-0.14%","FiveDayReturnAfter":"-1.78%","FiveDayReturnBefore":"6.58%"},{"Ticker":"NOV","EffectiveDate":"2012-05-16","Type":"Item_5.07","Title":"Submission of Matters to a Vote of Security Holders\r\n","DailyReturn":"-2.36%","FiveDayReturnAfter":"2.38%","FiveDayReturnBefore":"-6.07%"},{"Ticker":"NOV","EffectiveDate":"2012-05-16","Type":"RatingUpgrade","Title":"Standpoint Research upgrades NOV to Buy from Hold.","DailyReturn":"-2.36%","FiveDayReturnAfter":"2.38%","FiveDayReturnBefore":"-6.07%"},{"Ticker":"NOV","EffectiveDate":"2012-04-26","Type":"RatingNeutral","Title":"Citigroup maintains NOV to Buy. Target Price is $95; previously $91.","DailyReturn":"-0.11%","FiveDayReturnAfter":"-3.34%","FiveDayReturnBefore":"-2.82%"},{"Ticker":"NOV","EffectiveDate":"2012-04-26","Type":"RatingNeutral","Title":"RS Platou Markets maintains NOV to Buy. Target Price is $98; previously $100.","DailyReturn":"-0.11%","FiveDayReturnAfter":"-3.34%","FiveDayReturnBefore":"-2.82%"},{"Ticker":"NOV","EffectiveDate":"2012-04-25","Type":"EarningsRelease","Title":"Before market open, NOV reports 2012 Q1's earning $1.42 per share and revenue $4303MM..","DailyReturn":"-1.52%","FiveDayReturnAfter":"-3.4%","FiveDayReturnBefore":"-1.9%"},{"Ticker":"NOV","EffectiveDate":"2012-04-25","Type":"Item_2.02","Title":"Release results of operational and financial condition\r\n","DailyReturn":"-1.52%","FiveDayReturnAfter":"-3.4%","FiveDayReturnBefore":"-1.9%"},{"Ticker":"NOV","EffectiveDate":"2012-04-25","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":"-1.52%","FiveDayReturnAfter":"-3.4%","FiveDayReturnBefore":"-1.9%"},{"Ticker":"NOV","EffectiveDate":"2012-03-14","Type":"Dividend","Title":"The Firm pays dividend $0.10821","DailyReturn":"-1.92%","FiveDayReturnAfter":"0.14%","FiveDayReturnBefore":"5.42%"},{"Ticker":"NOV","EffectiveDate":"2012-02-21","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":"0.93%","FiveDayReturnAfter":"1.69%","FiveDayReturnBefore":"1.36%"},{"Ticker":"NOV","EffectiveDate":"2012-02-21","Type":"Item_5.02","Title":"Change of exectives and board members.\r\n","DailyReturn":"0.93%","FiveDayReturnAfter":"1.69%","FiveDayReturnBefore":"1.36%"}];